¡¶°ê»Ú¨xÀù¤À´Á¤ÎªvÀø·Ç«hBCLC¡]Barcelona Clinic Liver Cancer¡^¡C¡]¹Ï¡þNOW°·±d»s§@¡^
ªL¼Ý§Ó¥D¥ô«ü¥X¡A¦³¬ã¨s«ü¥X¡A65·³¥H¤W¨xÀù±wªÌ¬ù¦³¥|¦¨¶EÂ_¨S¦³«ùÄò±µ¨üªvÀø¡Cªñ¦~¨xÀù±ß´ÁªvÀø¤w¦³ÅãµÛ¶i¨B¡A§Y«KµLªk¤â³N¡A¤´¥i¦X¨Ö¦hºØÀøªk¡A¦p¤Æ¾Ç®ê¶ëªvÀø¡B¤fªA¼Ð¹vÃĪ«¡B§K¬ÌÀøªkµ¥¡A¤Á¤ÅÀH·N©ñ±óªvÀø¡I
¦X¨ÖªvÀø¥i¼W¥[¦s¬¡´Á ·s¿³¼Ð¹vÃĪ«¤w¦³°·«Oµ¹¥I
ªL¼Ý§Ó¥D¥ô¯S§O»¡©ú¡A¥Ø«e·s¿³ªº¼Ð¹v¤fªAÃĪ«¤w¦³°·«Oµ¹¥I¥i°µ¬°²Ä¤@½uªvÀø¤è¦¡¡A¾A¦XµLªk¤â³N¤Á°£¥B¤£¾A¦X§½³¡ªvÀøªº±ß´Á¨xÀù±wªÌ¡A¬ù¦³¤T¦Ü¥|¦¨ªº¤ÏÀ³²v¡C¨ä¾÷Âà»P¶Ç²Î¼Ð¹vÃĪ«¤£¦P¡A°£¥i§í¨î¸~²ÓM¥Íªø¡A§ó¥i¦P®É§í¨î¸~½F¦åºÞ²ÓM¼W¥Í¡A¥i¿×¡uÂù«§í¨î¾÷Âà¡v¡A¾ãÅé¦s¬¡´Á»P¶Ç²Î¼Ð¹vÃĪ«¬Û·í¥B¸~½F¤ÏÀ³²v¸û¨Î¡CÁ{§É¬ã¨sµo²{¡A¨ä¥i±æ©µªø±wªÌ¾ãÅé¦s¬¡´Á¡]overall survival, OS¡^¡]*¡^¤j©ó¤@¦~¡AµL´c¤Æ¦s¬¡´Á¡]progression-free survival, PFS¡^¡]**¡^¤Î¯e¯fµL´c¤Æ®É¶¡¡]time to progression, TTP¡^¡]***¡^¬Ò¹F¥b¦~¥H¤W¡A¤j³¡¤Àªº°Æ§@¥Î¤]³£¥i³Q§´µ½±±¨î¡C
ªL¼Ý§Ó¥D¥ô¶i¤@¨Bªí¥Ü¡A¦X¨Ö¨Ï¥Î¤Æ¾Ç®ê¶ë·f°t·s¿³¼Ð¹vÃĪ«§@¬°²Ä¤@½uªvÀø¤è¦¡¡AÁ{§ÉÆ[¹îµo²{¦³¨Ç±wªÌªº®ÄªG¬Û·í¦n¡CÕY¹J¨ì«ez90·³°ªÄֱߴÁ¨xÀùӮסA¤fªA¼Ð¹vÃĪ«µ¹ÃĤ覡²³æ¡A¬O¬Û·í¦X¾Aªº¿ï¾Ü¡C³Ì«á¡AªL¼Ý§Ó¥D¥ô¹ªÀy¥Á²³©w´Á±µ¨ü¨xÀù¿zÀË¡A¤~¯à¦´Áµo²{¤ÎªvÀø¡CY¤£©¯¿©±w¨xÀù¡A¥un¿n·¥°t¦XÂåÅñªvÀø¡A¯f±¡¤´¦³¾÷·|Àò±o²z·Qªº±±¨î¡I¡]³¯¦pÀ[¡þ¥x«n³ø¾É¡^
*¾ãÅé¦s¬¡´Á¡]overall survival, OS¡^¡A«ü¶}©l¥ÎÃĨ즺¤`ªº®É¶¡¡C
**µL´c¤Æ¦s¬¡´Á¡]progression-free survival, PFS¡^¡A«ü¶}©l¥ÎÃĨì¯e¯f´c¤Æ©Î¦º¤`ªº®É¶¡¡C
***¯e¯fµL´c¤Æ®É¶¡¡]time to progression, TTP¡^¡A«ü¶}©l¥ÎÃĨì¯e¯f´c¤Æªº®É¶¡¡A¦ý¤£¥]§t¦º¤`®×¨Ò¡C
¡]¹Ï¡þNOW°·±d»s§@¡F¹Ï¡þingimage¡^
¨Ó·½¡G³o3Ãþ¨xÀù¤£¾A¦X¤â³N¤Á°£¡I °·«Oµ¹¥I¼Ð¹vÃĪ«¨Ó§U°}
¥X³B¡GNOW°·±d